Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -2.50 (-0.94%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £127.20m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Directorate Changes

19 Feb 2024 07:00

RNS Number : 5033D
Quartix Technologies PLC
19 February 2024
 

Quartix Technologies plc

("Quartix", "the Group" or "the Company")

Directorate Changes

Quartix Technologies plc, a leading supplier of subscription-based vehicle tracking systems, analytical software and services is pleased to announce the appointment of Ian Spence as independent Non-Executive Director, effective from 19 February 2024. Ian will also Chair the Nomination Committee.

Ian has more than 25 years' experience in researching and advising companies in the technology sector. He is the Executive Chairman and Founder of Megabuyte, a leading company intelligence platform, delivering insights on the financial performance and corporate strategy of UK mid-market tech businesses.

Ian is recognized as one of the most established and respected financial analysts in the technology sector having been twice voted TechMARK Analyst of the Year, and also having been recognized twice by Debretts and The Sunday Times as one of the 20 most influential people in the technology sector in the United Kingdom.

Ian's other current roles include sitting as Non-Executive Director of Crown Place VCT PLC, a fund investing in early stage technology companies and as Principal at Agnosco Capital Ltd, where he provides research and strategic advice to technology companies and their investors.

Andy Walters, Executive Chairman, commented:

"We are delighted to announce Ian's appointment as an independent Non-Executive Director. Ian is one of the most distinguished tech analysts in the UK mid-market and we very much look forward to benefitting from his vast experience and market insight as we continue to execute on our growth strategy"

For further information, please contact:

Quartix (www.quartix.net)

Andy Walters, Executive Chairman

Emily Rees, Chief Financial Officer

01686 806 663

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Matt Goode / Seamus Fricker / Trisyia Jamaludin (Corporate Finance)

Tim Redfern / Sunila de Silva (Corporate Broking)

020 7220 0500

 

--------------------------------------------------------------------------------------------------------------------------------------

INFORMATION REQUIRED UNDER RULE 17 AND SCHEDULE 2, PARAGRAPH (G) OF THE AIM RULES FOR COMPANIES ("AIM RULES")

Full name:

Ian Angus Spence

Age:

53

Shares held in the Company:

Nil

 

Current directorships and/or partnerships:

Historic directorships and/or partnerships (within the last five years):

 

Agnosco Capital Limited

 

Crown Place VCT plc

 

IS Research Ltd (T/A Megabuyte)

 

 

IX Acquisition Corp Inc

 

 

There is no further information to be disclosed in relation to the appointment pursuant to Rule 17 and Schedule 2, paragraph (g) of the AIM Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKAKFFPLEFA
Date   Source Headline
25th Jul 20187:00 amRNSInterim Results
2nd Jul 20187:00 amRNSTrading Statement
26th Apr 20182:58 pmRNSDirector Share Transfer
23rd Apr 20187:00 amRNSQueen?s Award for Enterprise
27th Mar 20182:46 pmRNSExercise of Options
27th Mar 20182:42 pmRNSResult of AGM
27th Mar 20187:00 amRNSTrading Statement
12th Mar 20186:10 pmRNSDirector/PDMR Shareholding
26th Feb 20187:00 amRNSFinal Results
16th Jan 20185:33 pmRNSDirector/PDMR Shareholding
12th Jan 20187:00 amRNSTrading Statement
1st Dec 20171:29 pmRNSIssue of Equity & Directorate Changes
10th Nov 20177:00 amRNSHolding(s) in Company
8th Nov 20173:25 pmRNSHolding(s) in Company
27th Sep 20177:00 amRNSDirectorate Change
1st Aug 20177:00 amRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSDirectorate Changes
26th Jul 20177:00 amRNSInterim Results
3rd Jul 20177:00 amRNSTrading Update
21st Jun 20177:00 amRNSExercise of Options
18th Apr 201712:20 pmRNSDirector/PDMR Shareholding
13th Apr 20175:00 pmRNSHolding(s) in Company
30th Mar 201712:20 pmRNSHolding(s) in Company
30th Mar 20178:01 amRNSHolding(s) in Company
28th Mar 20171:20 pmRNSExercise of Options
28th Mar 201711:40 amRNSResult of AGM
28th Mar 20177:00 amRNSAGM Statement
9th Mar 201710:10 amRNSExercise of Options
2nd Mar 201711:13 amRNSDirector/PDMR Shareholding
27th Feb 20177:00 amRNSFinal Results
18th Jan 20177:00 amRNSTrading Statement
22nd Dec 20161:41 pmRNSHolding(s) in Company
15th Sep 20167:00 amRNSHolding(s) in Company
9th Aug 20169:13 amRNSExercise of Options
5th Aug 20164:12 pmRNSHolding(s) in Company
1st Aug 20169:43 amRNSPDMR Shareholding
27th Jul 20167:00 amRNSInterim Results
1st Jul 20167:00 amRNSTrading Update
19th Apr 20161:55 pmRNSDirector Share Transfer
4th Apr 20167:00 amRNSHolding(s) in Company
29th Mar 201612:16 pmRNSResult of AGM
29th Mar 20167:00 amRNSAGM Statement
29th Feb 20161:42 pmRNSExercise of Options
29th Feb 20167:00 amRNSFinal Results
15th Jan 20167:00 amRNSTrading Statement
21st Dec 20157:00 amRNSHolding in Company
17th Dec 20151:43 pmRNSExercise of Warrants
27th Oct 20153:00 pmRNSFRS 101 Adoption
23rd Oct 20154:10 pmRNSHolding(s) in Company
22nd Oct 20153:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.